FMR LLC
CIK 315066 · last filed 2026-07-24
FMR LLC is a corporate insider who has filed 164 SEC Form 4 insider transactions across 37 companies since 2009. The most recent filing, for GPCR, was dated Jul 24, 2026. Across all open-market trades the lifetime net is −$168.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $411.0M across reported positions. The firm reports its address in Boston, MA. 12 SEC filings were submitted jointly with Beam Therapeutics Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BEAM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GPCR | 10%+ Owner | 241,275 | $21.63 | $5.22M | $0 | 13 | 2026-07-24 |
| BEAM | 10%+ Owner | 1,106,071 | $24.80 | $27.44M | -$40.83M | 15 | 2026-06-29 |
| AVLN | 10%+ Owner | 727,585 | $25.41 | $18.48M | $0 | 1 | 2026-05-05 |
| Metsera, Inc. (MTSR) Delisted | 10%+ Owner | 3,010 | $70.50 | $212.2K | -$21.5K | 6 | 2025-11-12 |
| SANA | 10%+ Owner | 4,707,423 | $2.44 | $11.49M | -$1.89M | 1 | 2025-01-10 |
| BCAX | 10,818 | $17.30 | $187.2K | $0 | 1 | 2024-09-18 | |
| Turnstone Biologics Corp. (TSBX) Delisted | 10%+ Owner | 296,396 | $0.35 | $105.2K | $0 | 2 | 2024-01-11 |
| NMRA | 1,911,729 | $0.39 | $738.7K | $0 | 1 | 2023-09-21 | |
| PRME | 98,967 | $4.08 | $404.3K | $0 | 1 | 2022-10-26 | |
| Verve Therapeutics, Inc. (VERV) Delisted | 10%+ Owner | 570,729 | $11.13 | $6.35M | -$11.30M | 9 | 2022-07-28 |
| TOST | — | $32.07 | — | $0 | 1 | 2021-11-12 | |
| XLO | 319 | $7.29 | $2.3K | $0 | 1 | 2021-10-28 | |
| RLYB | 211,798 | $16.01 | $3.39M | $0 | 1 | 2021-08-04 | |
| CRBU | 17,572 | $0.47 | $8.3K | $0 | 1 | 2021-07-29 | |
| FLYW | 7,249,056 | $18.81 | $136.35M | $0 | 1 | 2021-06-02 | |
| Orchard Therapeutics plc (ORTX) Delisted | 10%+ Owner | 409,954 | $16.70 | $6.85M | -$14.43M | 3 | 2021-02-23 |
| DTIL | 124,608 | $6.57 | $818.7K | $800.0K | 1 | 2019-04-03 | |
| ViewRay, Inc. (VRAY) Delisted | 10%+ Owner | 1,620 | $0.03 | $40 | -$26.21M | 18 | 2018-08-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 1,888,986 | $1.07 | $2.02M | $0 | 1 | 2018-04-25 |
| Cogent Biosciences, Inc. (UMRX) Delisted | 1,890,701 | — | — | $1.13M | 1 | 2018-04-05 | |
| VYNE Therapeutics Inc. (MNLO) Delisted | 813,478 | — | — | $0 | 1 | 2018-01-31 | |
| DNLI | 31,969 | $19.08 | $610.0K | $0 | 1 | 2017-12-14 | |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 104 | $29.08 | $3.0K | $0 | 1 | 2017-07-06 | |
| KINETA, INC./DE (PTI) Delisted | 10%+ Owner | 12,175 | — | — | -$451.8K | 8 | 2017-03-15 |
| ACRS | 10%+ Owner | 1,931,727 | $3.80 | $7.34M | $3.61M | 6 | 2016-12-21 |
| EXA CORP (EXA) Delisted | 10%+ Owner | 0 | — | — | -$19.35M | 2 | 2016-10-11 |
| CHRS | 10%+ Owner | 361,594 | $1.04 | $377.9K | -$4.37M | 2 | 2016-08-10 |
| RGNX | 10%+ Owner | 619,376 | $6.59 | $4.08M | -$2.38M | 15 | 2016-05-18 |
| Dimension Therapeutics, Inc. (DMTX) Delisted | 10%+ Owner | 4,893,322 | — | — | $0 | 2 | 2016-05-03 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 496,813 | $129.46 | $64.32M | -$16.84M | 8 | 2015-11-30 |
| TETRAPHASE PHARMACEUTICALS INC (TTPH) Delisted | 10%+ Owner | 107,082 | — | — | $4.50M | 3 | 2015-03-09 |
| RARE | 10%+ Owner | 1,457,994 | $16.88 | $24.61M | $3.67M | 2 | 2014-08-05 |
| GNRC | 10%+ Owner | 763,071 | $193.12 | $147.36M | $1.28M | 1 | 2014-07-03 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 2,619,036 | — | — | -$13.6K | 4 | 2013-08-30 |
| INSM | 10%+ Owner | 2,575 | $94.05 | $242.2K | -$17.47M | 9 | 2013-07-23 |
| IRWD | 10%+ Owner | 837,736 | $3.48 | $2.92M | -$17.62M | 12 | 2013-04-02 |
| ASIA | 10%+ Owner | 498,711 | $37.91 | $18.91M | -$10.38M | 3 | 2010-09-22 |
Recent Filings
164 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-24 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2026-06-29 | BEAM | Sell (S) | −284,860 | -$10.04M | EDGAR |
| 2026-05-05 | AVLN | Conv (C) | +2,284,535 | $0 | EDGAR |
| 2026-04-16 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2026-01-20 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2025-12-10 | GPCR | Sell (S) | — | $0 | EDGAR |
| 2025-11-17 | — | Other (J) | −2,233,460 | $0 | |
| 2025-11-12 | Metsera, Inc. (MTSR) Delisted | Gift (G) | −860,722 | $0 | EDGAR |
| 2025-11-05 | Metsera, Inc. (MTSR) Delisted | Mixed | −570,085 | -$11.8K | EDGAR |
| 2025-10-29 | BEAM | Sell (S) | −459 | -$12.2K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.